Seventeen ambulatory men with ischemic heart disease were exercised before and after adminiition of one 40-mg sustained-action isosorbide dinitrate tablet. In f i e of them (group A) testing was done at half an hour, one, two and three hours, and in the other 12 patients (group B) two, four, six and eight h o w after medication to see whether the drug provided protection from e x e r c W i duced angina or displacement of the S T segment of the electrocardiograms. Fourteen patients had angina during exercise before therapy. In group A favorable resnlts were achieved with respect to disappearance of effortinduced angina pectoris and/or reduction or elhimtion of S T segment displacement until three hours after medication. In group B, three of nine patients who suffered from effort-induced angina were free from angina throughout the eight-hour testing. Another was protected through six hours. Two patients were free from angina at two, four and six hours, but not at eight hours. In one patient, angina was absent only at two and four hours, and in two patients only at six hours. All patients of group rganic nitrates have been administered orally for O some time as prophylaxis in patients with angina pectoris. Sustained-action formulations have been developed especially for such use. The efficacy of administering nitrates orally has been questioned, however. Needleman et all have suggested that orally administered nitrates are denitrated by the liver to pharmacologically inactive metabolites.
O some time as prophylaxis in patients with angina pectoris. Sustained-action formulations have been developed especially for such use. The efficacy of administering nitrates orally has been questioned, however. Needleman et all have suggested that orally administered nitrates are denitrated by the liver to pharmacologically inactive metabolites.
Yet vasodilatation after oral administration has been demonstrated unequivocally by finger plethysm~g r a p h y .~ Sustained-action oral formulations of both nitroglycerin and isosorbide dinitrate, while slower to act than sublingually or aerosol-administered nitroglycerin, did cause substantial changes in the finger pulse wave for many hours.
One of the methods of showing clinical efficacy of the nitrates involves exercise testing. Since angina results from inadequate oxygen supply to the myocardium, exercise, by increasing oxygen demands, often precipitates an anginal attack. Exercise testing has been used to show protection from exerciseinduced ischemia by a number of standard orally administered nitrate preparations"16 as well as specially formulated sustained-action preparati~ns.'~~~~~'~*'~ Negative results also have been r e p~r t e d . '~.~~ B had S T segment depression during exercise before therapy. In eight of them S T segment displacement was reduced or absent at eight hours, in only one at two, four and six hours, in one at two and four hours, and in one at four hours only. There was no effect at all in one patient Two patients repeated the testing procedure with Isosorbide dinitrate therapy several months after the initial testing. Results were nearly identical to those of the initial tests. These patients also repeated the tests with a placebo on the day following the second testing. Two other patients repeated the tests with a placebo approximately two weeks after the initial testing. There was no evidence of effect with administration of a placebo in any of the four patients, all of whom had been protected by sustained-action isosorbide dinitrate. The results of this stndy suggest a beneficial effect, lasting for eight hours, of sustained-action Isosorbide dinitrate on angina pectoris and effort-induced S T segmed displacement. Forther studies should be carried out to confirm these p d m b u y results.
The exercise studies of Russek et all"-l5 have shown duration of action of standard orally administered nitrate preparations to be as long as five hours. The purpose of our study was to determine duration of action, by exercise testing, of a sustained-action formulation of isosorbide dinitrate ( ISDN ) .
Seventeen ambulatory men with ischemic heart disease were studied. Ages ranged from 40 to 66 years. Duration of angina was from three months to 12 years in 16 patients; in one, angina had not been present for six months preceding the study. Twelve of the patients had had a myocardial infarction. Demographic details appear in Table 1 .
No prophylactic orally administered nitrate medications were used during the two weeks preceding the study. Other drugs which could have had an influence on the outcome of the trials also were discontinued.
About one and one-half hours after a standard light breakfast, each patient performed a multistaged workload test on a bicycle ergometer. All patients were familiar with this type of exercise testing. All had participated in the test before, and most of them were previously engaged in a reconditioning program of twice-weekly exercising on bicycle ergometer. The speed of "riding" on the bicycle ergometer was standardized, and in all patients it was the same. In our laboratory we use 45 cycles per minute. The electrocardiogram (ECG) was monitored continuously on an oscilloscope. A tracing was made before exercise and at one-minute intervals during and after exercise, until the ECG returned to the preexercise state. Blood pressure was also recorded at one-minute intervals with standard sphygomanometer. Each test began at 150 kpm/min. If the maximal tolerated workload had not been reached after six minutes, the exercise test was repeated at 300 kpm/min after a four-minute rest period. Such repetition was to continue at increments of 150 kpm/min until the maximal tolerable workload was reached.
After the maximal tolerable workload for each patient was established, exercise tests were repeated at the same workload after administration of one 40-mg sustained-action isosorbide dinitrate. Five patients (group A ) were exercised at half an hour, one, two and three hours after medication. In view of the favorable effect of ISDN in these patients, the design of the study was changed. The following 12 patients (group B) repeated the exercise test two, four, six and eight hours after medication. Monitoring was done just as in the tests before therapy. If angina did not occur in the final test and S-T segment displacement were absent or minimal, the patient repeated the exercise test at workloads greater each time by 150 kpm/min until his new maximal tolerable workload was reached. There was a four-minute rest period between tests.
Two patients repeated the exercise testing procedure with use of a placebo. The placebo testing in these patients occurred approximately two weeks after the initial testing with sustained-action isosorbide dinitrate. Tables 2 and 3 . Maximal tolerable workloads before drug administration were for at least three minutes 150 kpm/min in seven patients, 300 kpmlmin in eight patients, and 450 kpmlmin in two patients. All patients had S-T segment displacement of at least 2.0 mm. Fourteen had anginal pain.
Results appear in
In four of the five patients of group A (patients 1, 2, 3, 5 ) anginal pain disappeared half an hour after administration of ISDN. S-T segment displacement disappeared in one (patient 3) and was reduced in a second (patient 4). At the one, two-and three-hour tests all five patients of group A were without anginal pain. However, no change in S-T segment displacement occurred in one patient (patient 1 ) and only a reduction of S-T segment changes occurred in two other patients (2,5). In one of them S-T segment displacement of more than 2 mm reappeared at the three-hour test (patient 5).
Twelve patients of group B repeated exercise tests until eight hours after drug administration. Three of the nine patients with angina before medication 10, 14) were protected throughout the eight-hour testing period. Another (patient 9 ) was free from angina for six hours, but was not tested at eight hours after drug administration.
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Two patients (11, 16) had no angina for two, four and six hours, but angina reappeared after eight hours. Patient 15 was free from angina only at two and four hours; patient 6 and patient 12 only at six hours.
In 9 of the 12 patients of group B, S-T displacement was reduced or even disappeared. In four of them (patients 7, 8, 10, 14) there was no S-T displacement at the eight-hour test. In four others (6,9, 13, 16) there was at least 1.0 mrn less depression at the eight-hour test when compared with the test before therapy. In patient 17, S-T displacement of 2.0 mm, as in the test before therapy, reappeared at the eight-hour test.
Patient 15 had no S-T displacement at two and four hours. Patient 12 had no S-T displacement at four hours only. Patient 11 showed no change at all.
Protection from anginal pain generally paralleled reduction or absence of S-T segment displacement. At the eight-hour test, all patients who had angina protection also had no S-T displacement at their predrug maximal tolerated workloads. Patient 11, however, was free from anginal pain at two, four and six hours; S-T displacement was never evident.
Five of 12 patients of group B (7, 8, 10, 13, 14) were able to perform greater amounts of work eight hours after administration of sustained-action isosorbide dinitrate than during exercise before the .
therapy. In two of these, exercise was finally discontinued due to reasons other than angina or S-T displacement In patient 10, angina had not occurred and S-T displacement was only 1.0 mm when exercise was stopped after 450 kpmlmin for four minutes due to fatigue; maximal tolerated workload before therapy had been 300 kpmlmin for three minutes. In patient 17, testing was terminated after therapy after 150 kpmlrnin for four minutes because of multiple ventricular extrasystoles and S-T segment depression. At his maximal tolerated workload of 150 kpmlmin for five minutes before therapy, similar S-T segment depression and extrasystoles were found.
Results of the second trial with sustained-action isosorbide dinitrate (patients 14 and 15) were quite similar to those of the initial testing. Maximal tolerable workload at the pre-drug test was greater in the second trial in patient 14. But drug effect, demonstrated through eight hours in the k t trial, was absent at eight hours in the second trial. In patient 15, results of the second trial were identical to those of the first, except for less S-T segment displacement at six hours in the second trial.
Placebo administration to both patient 14 and patient 15 on the day following the second drug trial resulted in no protection through the fourth hour, at which time testing was discontinued. Drug effect through the fourth hour had been demonstrated previously in both patients.
Placebo administration to two other patients (16, 17) , approximately two weeks after the initial testing with sustained-action isosorbide dinitrate, also resulted in no protection through the fourth hour. Extended drug effect had been demonstrated previously in both patients.
Patient 10 had a severe headache one-half hour after taking sustained-action isosorbide dinitrate. There were no other side effects. Figure 1 presents the number of group B patients who suffered from anginal pain before and after drug test, respectively. Figure 2 shows the average S-T displacement in millimeters at the various stages of the tests in patients of group B.
Following are brief descriptions of representative patients.
The patient was a 66-year-old man who had had angina for three months ( Fig 1 ) . The electrocardiogram revealed nega- 
I 3 rosr ISDN without angina appeared again.
CASE 15 ( Fig 2 ) This 61-year-old man had had angina for two years. The electrocardiogram showed negative T waves in V3, Vr, and
Va. Before drug administration, S-T segment displacement of 3.0 mm and severe angina appeared at a workload of 300 kpm/min for four minutes. Two, four and six hours after administration of 40 mg sustained-action isosorbide dinitrate, the patient exercised at the same workload without angina and without or with minor S-T segment displacement. At the eight-hour test, after 300 kpm/min for four minutes, S-T segment displacement and angina pain reappeared. The next The electrocardiogram of this 58-~earsld man, who had had angina for two years, showed T-wave abnormalities. Before drug administration, distinct S-T segment displacement of 3.0 mm and anginal pain appeared at an effort of 150 kpm/min for six minutes. The S-T segment depression became nearly isoelectric after a rest of four minutes. At the two, four and six-hour tests, no S-T segment depression and no pains appeared after the same workload. After eight hours, anginal pain and S-T segment depression of 3.0 mm appeared. The next day, the work load tests were repeated after placebo administration. Deep S-T segment displacement and anginal pains appeared at a workload of 150 k p d m i n for six minutes before placebo administration, as well as after two and four hours.
This 80-year-old man suffered myocardial infarction one year ago and had had angina for one year. The electrocardiogram showed previous posterior infarction, slight S-T segment depression in Va and Va, ventricular extrasystoles Before drug administration, S-T segment displacement of 2.0 m m without anginal pain appeared after a workload of 150 kpm/min for five minutes. The test was discontinued for multiple ventricular extrasystoles. The S-T segment depression disappeared after a rest of seven minutes. Two, four and six h o w after administration of 40 mg sustained action isosorbide dinitrate the patient performed a workload of 150 kpm/min for five minutes without extrasystoles or additional S-T segment displacement. After eight hours, at a workload of 150 kpm/min for four minutes, marked S-T segment depression, bigeminy, multiple ventricular extrasystoles and anginal pain appeared, which disappeared after a rest of four minutes. The next day the tests were repeated. This time the rest-ECG did not show extrasystdes. At the preplacebo workload test of 150 kpm/min for four minutes, deep S-T segment depression of 3.0 mm and anginal pain appeared, but no extra-systoles. Two and four hours after placebo administration, at the same workload, similar S-T segment depression and multiple extrasystoles were recorded, but no angina.
DISCUSSION AND CONCLUSIONS The exercise testing method was used to show that sustained-action isosorbide dinitrate afforded protection from anginal pain and displacement of the S-T segment of the ECG. Duration of drug action was variable, as expected, but the effect lasted at least eight hours in some patients.
The basic premise of the exercise testing method is that a drug effect can be shown when work which has caused anginal pain and S-T segment displacement (before medication) can be repeated without pain or displacement ( after medication ) . This premise can be accepted on the basis of the work of several investigators who were able to demonstrate that repeated exercise testing per se has no effect on exercise t~lerance.*l-~~ We are aware that our trial was not carried out as a double-blind study. There are also certain limits in encouraging patients with coronary disease to perform exercise testing five times on the same day, and to repeat it on one of the following days.
The premise of the exercise testing method as well as the conclusions of this study are supported by the results obtained with administration of a placebo.
